Bioscience Chapter Database :: 3635 Chapters Now Online

Chapter category: Oncogenes

The p53-Mdm2 Loop A Critical Juncture of Stress Response

This chapter appears in the following book:

p53

Edited by: Theodore Hupp and Ayeda Ayed
ISBN: TBA141
» Get more information about this book at landesbioscience.com «

Chapter authors:
Zehavit Goldberg, Igal Louria-Hayon, Tamar Grossman, Michael Berger and Ygal Haupt


[+] view image
The presence of a functional p53 protein is a key factor for the proper suppression of cancer development. A loss of p53 activity, by mutations or inhibition, is often associ ated with human malignancies. The p53 protein integrates various stress signals into a growth restrictive cellular response. In this way, p53 eliminates cells with a potential to become cancerous. Being a powerful decision maker, it is imperative that p53 will be activated properly, efficiently and temporarily in response to stress. Equally important is that p53 activation will be extinguished upon recovery from stress, and that false activation of p53 will be avoided. Failure to achieve these aims is likely to have catastrophic consequences for the organism. The machinery that governs this tight regulation is largely based on the major inhibitor of p53, Mdm2, which both blocks p53 activities and promotes its destabilization. The interplay between p53 and Mdm2 involves a complex network of positive and negative feedback loops. Relief from Mdm2 suppression is required for p53 to be stabilized and activated in response to stress. Protection from Mdm2 entails a concerted action of modifying enzymes and partner proteins. The association of p53 with the PML-nuclear bodies may provide an infrastructure in which this complex regulatory network can be orchestrated. In this chapter we use examples to illustrate the regulatory machinery that drives this network.

» Access chapter for $19



Additional chapters from this book:

Lessons on p53 from Mouse Models

Laura D. Attardi*

Mutations in the p53 gene are implicated in the development of at least half of all human cancers, of a wide variety of types.1,2 This high incidence of mutations suggests that there exists a strong...

TP63, TP73: The Guardian’s Elder Brothers

Stephanie Courtois, Pierre Hainaut and Claude Caron de Fromentel

TP73 and TP63 recently emerged as sharing overall architectural similarities with TP53. Phylogeny indicates that these three genes derive from a common ancestor, thus defining a new gene family. All...

Modes of p53 Interactions with DNA in the Chromatin Context

Vladana Vukojevic, Tatiana Yakovleva and Georgy Bakalkin

The tumor suppressor p53, a sequence-specific transcription factor playing a central role in cancer surveillance, exerts its main functions by activating or repressing transcrip tion of its target g...

TP53 Mutations in Human Cancers: Selection versus Mutagenesis and Pierre Hainaut

Magali Olivier, Stephanie Courtois, Claude Caron de Fromentel and Pierre Hainaut

TP53 differs from most other cancer-related genes by the very high prevalence of missense mutations which result in the expression of a mutant protein. Considerable variations are observed between m...

Tumor Viruses and p53

Nobuo Horikoshi

Viruses are potent oncogenic agents and are considered to link to approximately one-fifth of all human malignancies. The study of tumor viruses has provided fundamental bases of how normal cells bec...

The p53-Mdm2 Loop A Critical Juncture of Stress Response

Zehavit Goldberg, Igal Louria-Hayon, Tamar Grossman, Michael Berger and Ygal Haupt

The presence of a functional p53 protein is a key factor for the proper suppression of cancer development. A loss of p53 activity, by mutations or inhibition, is often associ ated with human maligna...

Regulation of p53 Localization

Tomomi Inoue, Carl G. Maki

The tumor suppressor protein p53 is one of the most intensely studied molecules in modern cancer biology, and with good reason. Inactivating mutations in the p53 gene are observed in over 50% of all...

p53’s Dilemma in Transcription: Analysis by Microarrays

Karuppiah Kannan, Gideon Rechavi and David Givol

Protection against cancer by p53 is due mainly to its activity as a transcription factor. The function of p53 in transactivation of target genes is analyzed here with emphasis on the dilemma between...


SIGN IN

Email:


Password:


lost password?




[ Home | Authors | Editors | Custom Books | Chapter Reprints | Subscribe | Contact | Biotoons ]